سعر نازو-سيانوكوبالامين 500مكجم/جرعة سبراي للانف 2.3 مل 2022

• Maintenance therapy in pernicious anaemia in remission after IM B12 (no nervous-system involvement)Population: AdultsDailyMed (U.S. National Library of Medicine)
• Dietary, drug-induced or malabsorption-related B12 deficiency not due to pernicious anaemia; prevention when requirements exceed normalPopulation: AdultsDailyMed (U.S. National Library of Medicine)

• Most common (>=4%): infection, headache, glossitis, paraesthesia, asthenia, nausea and rhinitis.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Hypersensitivity to cobalt and/or vitamin B12 or any excipient.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Not recommended in early Leber's disease (severe, swift optic atrophy); anaphylaxis reported with parenteral B12 - consider an intradermal test dose if hypersensitivity is suspected; doses above 10 mcg/day may mask folate deficiency; hypokalaemia and thrombocytosis can occur when megaloblastic anaemia is treated intensively.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• ChloramphenicolMay decrease efficacy when used for anaemia; monitor and consider alternative therapy.DailyMed (U.S. National Library of Medicine)

• Limited data are insufficient to inform drug-associated risk; vitamin B12 is essential and requirements increase in pregnancy.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Present in milk at concentrations approximating maternal blood levels; no more than minimal risk to the breastfed child.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

English text not available for this section.